Debate: Does it matter how you lower blood pressure?

Current Controlled Trials in Cardiovascular Medicine

关键词: antihypertensive drugs;    antihypertensive therapy;    clinical trials;    hypertension;   

DOI  :  10.1186/cvm-1-2-069

来源: DOAJ

【 摘 要 】

Abstract

Whether it matters how pressure is lowered has been debated since antihypertensive drugs proved to prevent cardiovascular events. However, in clinical trials, while the stroke benefit predicted by a given difference in blood pressure was achieved, the results for myocardial infarction were roughly half that expected. This suggested that adverse drug effects of diuretics and β-blockers might have detracted from their hypotensive effects. Trials with newer antihypertensive classes have revealed superior effects on outcomes associated with converting enzyme inhibitor use, and that α-blockers are less cardioprotective than diuretics. These studies establish that simple blood pressure reduction is an inadequate guide to therapy. The challenge now will be to determine the optimal therapy for each hypertensive patient.

【 授权许可】

Unknown